Physical Activity and Sedentary Behaviour in Patients With Inflammatory Bowel Disease
PASIBO
1 other identifier
interventional
30
1 country
1
Brief Summary
Emerging research suggests that physical activity may improve health-related quality of life (HrQoL) in patients with inflammatory bowel disease (IBD) and positively influence physical symptoms, fatigue, stress and anxiety. However, little is known about detailed movement patterns and their specific health effects in IBD patients or about patients' wishes, motivation and preferences for physical activity in their everyday lives. Based on exisiting evidence, the investigators' hypothesis is that an individually tailored, behavioural intervention focusing on reducing sedentary behaviour and increasing daily physical activity is feasible and effective in patients with IBD. Therefore, the overall aim of this randomized feasibility study is to determine the feasibility of the behavioural intervention, including the testing of recruitment procedures, intervention adherence, retention and outcome assessments. Intervention participants will undergo:
- An one-hour individual session with a physiotherapist
- Being teamed up with 1-2 'exercise buddies' (other intervention participants) and/or
- Access to four short 2-3 minutes videos/'reels' of a physiotherapist explaining and demonstrating beneficial physical exercises Results from the present feasibility study will determine if and how to proceed with a large-scale randomized controlled trial evaluating the efficacy of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2023
CompletedFirst Posted
Study publicly available on registry
October 30, 2023
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2024
CompletedJanuary 30, 2025
January 1, 2025
10 months
October 24, 2023
January 29, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Recruitment
Recruitment rates will be calculated as the proportion of patients randomised/proportion of patients eligible
Assessed at 3 months after baseline
Retention
Retention rates will be calculated as the proportion of patients providing the outcomes of interest/proportion of patients randomised
Assessed at 5 months (20 weeks)
Intervention adherence
Adherence to intervention protocol will be calculated as the number of group and motivational counselling sessions attended out of the total number of sessions available
Assessed at 5 months (20 weeks)
Intervention acceptability
Acceptability of intervention protocol will be calculated as the number of received optional elements of the intervention out of the total number of optional intervention elements available
Assessed at 5 months (20 weeks)
Secondary Outcomes (18)
Objectively measured physical activity measured by SENS monitor
Assessed at baseline and at 5 months (20 weeks)
Self-reported physical activity and sitting time measured by the Physical Activity Scale (PAS)
Assessed at baseline and at 5 months (20 weeks)
Exercise self-efficacy measured by the Exercise Self-Efficacy Scale
Assessed at baseline and at 5 months (20 weeks)
Health-related quality of life measured by the Inflammatory Bowel Disease Questionnaire (IBDQ)
Assessed at baseline and at 5 months (20 weeks)
Fatigue measured by The Multi-dimensional Fatigue Inventory (MFI-20)
Assessed at baseline and at 5 months (20 weeks)
- +13 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALThis group will undergo a 20-week individually tailored, behavioral intervention
Control group
NO INTERVENTIONThis group will be encouraged to maintain usual lifestyle and activities.
Interventions
A 20-week intervention with a basic part, including 1. A group session with education about IBD,physical activity and exercise in relation to IBD (definitions, evidence and recommendations). Furthermore, access to a video with general information about IBD, physical activity and exercise 2. Four individual motivational counselling sessions (two physical, two by telephone) with a project nurse. These will involve identifying individual motivation and opportunities for increasing physical activity and behavioral goal setting. An optional intervention part will follow, including choises between (or all of) 1. A one-hour individual session with a physiotherapist, involving guidance in physical activity and exercise tailored to the individual. 2. Being teamed up with 1-2 'exercise buddies' (other participants from the overall intervention group). 3. Access to 4 short 2-3 minutes videos/'reels' of a physiotherapist explaining and demonstrating beneficial physical exercises.
Eligibility Criteria
You may qualify if:
- A diagnosis of IBD (Crohn's disease or ulcerative colitis) \> 1 year
- Over 18 years of age
- Minimum three months stable medication type and dose without use of steroids as part of the medical treatment during the last three months
- Speak and understand Danish
You may not qualify if:
- Unable to give informed consent
- Active inflammatory disease in joints, skin, pancreas, thyroid, lungs or liver that can hinder engagement in physical activity and exercise
- Cognitive and/or mental disabilities that can hinder engagement in physical activity and exercise
- Engaging in high-intensity physical activity -/\> 8 hours pr week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Center for Clinical Research and Preventionlead
- Bispebjerg Hospitalcollaborator
Study Sites (1)
Digestive Disease Center, BFH
Copenhagen, 2400, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mette Aadahl, PhD
Professor at Center for Clinical Research and Prevention
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Allocation status of study participants will not be revealed for the project nurses that conduct the outcome assessments
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoc
Study Record Dates
First Submitted
October 24, 2023
First Posted
October 30, 2023
Study Start
November 15, 2023
Primary Completion
September 3, 2024
Study Completion
September 3, 2024
Last Updated
January 30, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
As this is a feasibility study, sharing of outcome data is not relevant